Refine by
Microsurgical Articles & Analysis
48 news found
An innovative Australian micro screw created to help significantly reduce complications in the management of orthopaedic injuries and the fixing of fractures in the hand and wrist will be used in a world-first operation in Brisbane by internationally-renowned hand surgeon Dr Greg Couzens on Wednesday 30 January. The Field Micro Screw by Brisbane med-tech start-up Field Orthopaedics has already ...
We would like to announce that Dr. Maria Mani is our newest member of our Medical Advisory Board. Maria is an associate professor, senior lecturer and director of the plastic and reconstructive microsurgery department at the Uppsala University Hospital. ...
Come and visit us at booth 8 (1-4 June) to learn about our newest generation microsurgical robot. Update: After a year of absence due to the pandemic, the World Society of Reconstructive Microsurgery could celebrate its 11th Congress in Cancun from 1-4 June 2022. ...
CO2 fractional laser resurfacing machine treatment can quickly improve skin texture, firm skin, improve large pores, and make skin smooth and tender like water. CO2 fractional laser technology is now the world's leading technology for wrinkle removal and skin rejuvenation. Through pulsed fractional laser, laser beauty has been raised to a new level. Bvlaser is a professional CO2 fractional laser ...
HIFU is the abbreviation of high intensity focused ultrasound. It uses focused ultrasound energy to accurately inject the dermis, subcutaneous tissue, and SMAS (facial superficial aponeurotic system) fascia layer of the skin to increase the temperature of the target site and initiate collagen regeneration and firming. There are two keys to HIFU skin tightening machine treatment: depth and ...
"We're excited that our innovative solutions will allow more surgeons to perform microsurgical techniques and help expand patient access to supermicrosurgeries for chronic illnesses like lymphedema, a burdensome condition that affects 250 million people around the ...
"We're pleased to have bridged the Atlantic with premier U.S. life science investors, and existing European investors, who share our same vision of bringing microsurgical robotics to the world." The company's new board members are Andrew ElBardissi, MD, Tess Cameron and Arturo Baroncelli. ...
With the funding, MUSA-3, a new generation microsurgical robot will be developed where safety, usability, dexterity and ergonomics will be improved. ...
OnLume has received 510(k) clearance from the U.S. Food & Drug Administration (“FDA”) to market its first product, a fluorescence guided surgery (FGS) system. The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries. This ...
OnLume Inc., an early stage medical imaging company with unique technology for improving surgical precision, has been awarded a substantial grant from the U.S. National Institutes of Health (NIH)’s National Cancer Institute (NCI) to advance development of its proprietary device for Fluorescence-Guided Surgery (FGS). OnLume has developed novel FGS imaging technology to illuminate critical ...
OnLume Inc., a Madison, Wisconsin-based medical imaging company with unique technology for improving surgical precision in the operating room, has announced the start of participation in a clinical trial combining its fluorescence-guided surgery (FGS) imaging device with a novel nerve-targeting agent. OnLume has unique FGS imaging technology to illuminate critical anatomy in real time during ...
Microsure and Olympus teamed up in the world’s first case in plastic surgery in which robotic microsurgery was combined with their newest digital exoscope. Microsure’s MUSA and the Olympus OrbEye 3D 4K camera were used during a clinical case. With this set-up the surgeon is able to do so-called “heads up microsurgery”, which means the surgeon does not have to look through ...
PISA, Italy. June 8.2022 - Medical Microinstruments (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced that it will participate in "THE MINIMALLY INVASIVE ROBOTIC SURGERY SYSTEMS project (TREMIRS). REFERENCE: CPI-2019-33-1-TRE-14. in the framework of the Line for the Promotion of Innovation from the Demand for the Public ...
Once a discontinuous nerve injury is identified, the intrinsic ability of the peripheral nervous system to restore that damage is not sufficient and requires microsurgical interventions to support regeneration across the defect. The multilayered silk-based structure of SILKBridge® is developed to confer ideal porosity and compression resistance to the device to promote safe ...
ByKLISBio
The simulator will improve, expand, and digitize the pathways for Symani training as surgeons prepare to expand their microsurgical skills through robotics. "It was a priority for our company to offer our surgeons a simulation solution so they can practice robotic microsurgery in a more convenient way," said Mark Toland, CEO of MMI SpA. ...
The state-of-the-art facility will serve as the global 'Center of Excellence' for microsurgical surgical robotics, encompassing development, manufacturing, and administration. ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has commenced a Phase 2 clinical program for its third-generationiLink™ therapy designed to treat keratoconus. ...
Lightpoint Medical today announced that Dr. Doug Adams, a specialist in robotic thoracic surgery at Bethesda North Hospital (part of TriHealth, Ohio) performed a first-in-the-world lung procedure with SENSEI, the company's new miniature robotic gamma probe. SENSEI is smaller than an AA battery and designed specifically for robotic and minimally-invasive surgery. The miniature size and ...
By improving the quality of microsurgical procedures via precision and dexterity and making them easier to perform, Microsure hopes to increase the number of treatment options for patients. ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has enrolled the first patient into a Phase 2 clinical trial of GLK-302 for the treatment of presbyopia. GLK-302 is the second investigational ...